Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function

Journal of Clinical Investigation

Volumn 121, Issue 12, 2011, Pages 4640-4654

  Shen, Tao ^a,b   Aneas, Ivy ^c   Sakabe, Noboru ^c   Dirschinger, Ralf J ^a   Wang, Gang ^a   Smemo, Scott ^c   Westlund, John M ^c   Cheng, Hongqiang ^d   Dalton, Nancy ^d   Gu, Yusu ^d   Boogerd, Cornelis J ^a   Cai, Chen Leng ^a,e   Peterson, Kirk ^d   Chen, Ju ^d   Nobrega, Marcelo A ^c   Evans, Sylvia M ^a,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b BEIJING HOSPITAL   (China)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; ION CHANNEL; MUSCLE PROTEIN; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TBX20; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BIOINFORMATICS; CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; GENE EXPRESSION; GENE LOSS; GENE MUTATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; HEART ARRHYTHMIA; HEART DEATH; HEART DISEASE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DNA BINDING;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ARRHYTHMIAS, CARDIAC; BINDING SITES; CARDIOMYOPATHIES; CHROMATIN IMMUNOPRECIPITATION; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION; GENES, REPORTER; HEART; HEART FAILURE; HUMANS; ION CHANNELS; ION TRANSPORT; MALE; MICE; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; T-BOX DOMAIN PROTEINS; TRANSCRIPTION FACTORS; ZEBRAFISH;

EID: 84055193910     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI59472     Document Type: Article

References (89)

1. Kirk EP, et al. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet. 2007;81(2):280-291. (Pubitemid 47236076)
2. Liu C, Shen A, Li X, Jiao W, Zhang X, Li Z. T-box transcription factor TBX20 mutations in Chinese patients with congenital heart disease. Eur J Med Genet. 2008;51(6):580-587.
3. Posch MG, et al. A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects. J Med Genet. 2010;47(4):230-235.
4. Sotoodehnia N, et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet. 2010;42(12):1068-1076.
5. Cai CL, et al. T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis. Development. 2005;132(10):2475- 2487.
6. Stennard FA, et al. Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation. Development. 2005;132(10):2451-2462. (Pubitemid 40872813)
7. Takeuchi JK, et al. Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development. Development. 2005;132(10):2463-2474. (Pubitemid 40872814)
8. Singh MK, et al. Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2. Development. 2005;132(12):2697-2707. (Pubitemid 40932861)
9. Stennard FA, et al. Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart. Dev Biol. 2003;262(2):206-224. (Pubitemid 37194503)
10. Brown DD, et al. Tbx5 and Tbx20 act synergistically to control vertebrate heart morphogenesis. Development. 2005;132(3):553-563. (Pubitemid 40277695)
11. Benson DW, et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest. 1999; 104(11):1567-1573. (Pubitemid 30002368)
12. Dentice M, et al. Missense mutation in the tran scription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis. J Clin Endocrinol Metab. 2006;91(4):1428-1433.
13. Garg V, et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature. 2003;424(6947):443-447. (Pubitemid 36917494)
14. Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with tetralogy of fallot. Circulation. 2001;104(21):2565-2568. (Pubitemid 33104794)
15. Gutierrez-Roelens I, et al. A novel CSX/NKX2-5 mutation causes autosomal-dominant AV block: are atrial fibrillation and syncopes part of the phenotype? Eur J Hum Genet. 2006;14(12):1313-1316. (Pubitemid 44804039)
16. Hirayama-Yamada K, et al. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A. 2005;135(1):47-52. (Pubitemid 40627663)
17. Inga A, Reamon-Buettner SM, Borlak J, Resnick MA. Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system. Hum Mol Genet. 2005;14(14):1965-1975. (Pubitemid 41418033)
18. Rauch R, et al. Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot. J Med Genet. 2010;47(5):321-331.
19. Reamon-Buettner SM, Borlak J. Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease. J Med Genet. 2004; 41(9):684-690. (Pubitemid 39208609)
20. Schott JJ, et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science. 1998;281(5373):108-111.
21. Pfeufer A, et al. Genome-wide association study of PR interval. Nat Genet. 2010;42(2):153-159.
22. Li QY, et al. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet. 1997;15(1):21-29. (Pubitemid 27014945)
23. Basson CT, et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet. 1997;15(1):30-35.
24. Pashmforoush M, et al. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell. 2004; 117(3):373-386. (Pubitemid 38534543)
25. Oka T, et al. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res. 2006;98(6):837-845.
26. Zeisberg EM, et al. Morphogenesis of the right ventricle requires myocardial expression of Gata4. J Clin Invest. 2005;115(6):1522-1531. (Pubitemid 40814660)
27. Bisping E, et al. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci U S A. 2006;103(39):14471-14476. (Pubitemid 44484774)
28. Bruneau BG, et al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell. 2001;106(6):709-721. (Pubitemid 32900662)
29. Mori AD, et al. Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis. Dev Biol. 2006;297(2):566-586. (Pubitemid 44354936)
30. Ashburner M, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25-29. (Pubitemid 30257031)
31. He A, Kong SW, Ma Q, Pu WT. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc Natl Acad Sci U S A. 2011;108(14):5632-5637.
32. Visel A, et al. ChIP-seq accurately predicts tissue- specific activity of enhancers. Nature. 2009; 457(7231):854-858.
33. Macindoe I, et al. Conformational stability and DNA binding specificity of the cardiac T-box transcription factor Tbx20. J Mol Biol. 2009;389(3):606-618.
34. Newburger DE, Bulyk ML. UniPROBE: an online database of protein binding microarray data on protein-DNA interactions. Nucleic Acids Res. 2009; 37(Database issue):D77-D82.
35. Bryne JC, et al. JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update. Nucleic Acids Res. 2008;36(Database issue):D102-D106.
36. Matys V, et al. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 2003;31(1):374-378. (Pubitemid 36150406)
37. Gotea V, Visel A, Westlund JM, Nobrega MA, Pennacchio LA, Ovcharenko I. Homotypic clusters of transcription factor binding sites are a key component of human promoters and enhancers. Genome Res. 2010;20(5):565-577.
38. Narlikar L, et al. Genome-wide discovery of human heart enhancers. Genome Res. 2010;20(3):381-392.
39. Taher L, et al. Genome-wide identification of conserved regulatory function in diverged sequences. Genome Res. 2011;21(7):1139-1149.
40. Dufour CR, et al. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab. 2007; 5(5):345-356. (Pubitemid 46667756)
41. Barry DM, Xu H, Schuessler RB, Nerbonne JM. Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 alpha subunit. Circ Res. 1998;83(5):560-567. (Pubitemid 28411058)
42. Bettahi I, Marker CL, Roman MI, Wickman K. Contribution of the Kir3.1 subunit to the muscarinicgated atrial potassium channel IKACh. J Biol Chem. 2002;277(50):48282-48288. (Pubitemid 35470781)
43. Guo W, et al. Targeted deletion of Kv4.2 eliminates I(to,f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction. Circ Res. 2005; 97(12):1342-1350.
44. Gutstein DE, et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res. 2001; 88(3):333-339. (Pubitemid 32173758)
45. Gutstein DE, et al. Heterogeneous expression of Gap junction channels in the heart leads to conduction defects and ventricular dysfunction. Circulation. 2001;104(10):1194-1199. (Pubitemid 32830407)
46. Kuo HC, et al. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell. 2001;107(6):801-813.
47. Periasamy M, et al. Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. J Biol Chem. 1999; 274(4):2556-2562.
48. Qian L, et al. Transcription factor neuromancer/ TBX20 is required for cardiac function in Drosophila with implications for human heart disease. Proc Natl Acad Sci U S A. 2008;105(50):19833-19838.
49. Seisenberger C, et al. Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. J Biol Chem. 2000;275(50):39193-39199. (Pubitemid 32058936)
50. Takeshima H, Komazaki S, Hirose K, Nishi M, Noda T, Iino M. Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2. EMBO J. 1998;17(12):3309-3316. (Pubitemid 28279505)
51. Zaritsky JJ, Redell JB, Tempel BL, Schwarz TL. The consequences of disrupting cardiac inwardly rectifying K(+) current (I(K1)) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes. J Physiol. 2001;533(pt 3):697-710. (Pubitemid 32600525)
52. Zheng M, et al. Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death. Hum Mol Genet. 2009; 18(4):701-713.
53. Zhou Q, et al. Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J Cell Biol. 2001;155(4):605-612. (Pubitemid 34289318)
54. Priori SG, Napolitano C. Role of genetic analyses in cardiology: part I: mendelian diseases: cardiac channelopathies. Circulation. 2006;113(8):1130-1135.
55. Lehnart SE, et al. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation. 2007;116(20):2325-2345. (Pubitemid 350100339)
56. Watkins H, Ashrafian H, Redwood C. Inherited cardiomyopathies. N Engl J Med. 2011; 364(17):1643-1656.
57. Richards AA, Garg V. Genetics of congenital heart disease. Curr Cardiol Rev. 2010;6(2):91-97.
58. Roberts JD, Gollob MH. The genetic and clinical features of cardiac channelopathies. Future Cardiol. 2010;6(4):491-506.
59. Lakdawala NK, Givertz MM. Dilated cardiomyopathy with conduction disease and arrhythmia. Circulation. 2010;122(5):527-534.
60. He A, Kong SW, Ma Q, Pu WT. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc Natl Acad Sci U S A. 2011;108(14):5632-5637.
61. Chen Z, Friedrich GA, Soriano P. Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Genes Dev. 1994;8(19):2293-2301. (Pubitemid 24314291)
62. Deblois G, Giguere V. Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease. Biochim Biophys Acta. 2011; 1812(8):1032-1040.
63. Gass P, et al. Deficits in memory tasks of mice with CREB mutations depend on gene dosage. Learn Mem. 1998;5(4-5):274-288. (Pubitemid 29115259)
64. Heallen T, et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science. 2011;332(6028):458-461.
65. Hummler E, et al. Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors. Proc Natl Acad Sci U S A. 1994;91(12):5647-5651. (Pubitemid 24174385)
66. Lin Q, Schwarz J, Bucana C, Olson EN. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science. 1997;276(5317):1404-1407. (Pubitemid 27235406)
67. Naya FJ, et al. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat Med. 2002;8(11):1303-1309. (Pubitemid 35373564)
68. Potthoff MJ, Olson EN. MEF2: a central regulator of diverse developmental programs. Development. 2007;134(23):4131-4140.
69. Rudolph D, Tafuri A, Gass P, Hammerling GJ, Arnold B, Schutz G. Impaired fetal T cell development and perinatal lethality in mice lacking the cAMP response element binding protein. Proc Natl Acad Sci U S A. 1998;95(8):4481- 4486. (Pubitemid 28207938)
70. Sawada A, Kiyonari H, Ukita K, Nishioka N, Imuta Y, Sasaki H. Redundant roles of Tead1 and Tead2 in notochord development and the regulation of cell proliferation and survival. Mol Cell Biol. 2008; 28(10):3177-3189. (Pubitemid 351657083)
71. Vong L, Bi W, O'Connor-Halligan KE, Li C, Cserjesi P, Schwarz JJ. MEF2C is required for the normal allocation of cells between the ventricular and sinoatrial precursors of the primary heart field. Dev Dyn. 2006;235(7):1809- 1821. (Pubitemid 43902340)
72. Hammer S, et al. Characterization of TBX20 in human hearts and its regulation by TFAP2. J Cell Biochem. 2008;104(3):1022-1033. (Pubitemid 351830848)
73. Mandel EM, et al. The BMP pathway acts to directly regulate Tbx20 in the developing heart. Development. 2010;137(11):1919-1929.
74. Sohal DS, et al. Temporally regulated and tissue- specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res. 2001;89(1):20-25. (Pubitemid 34135487)
75. Zambrowicz BP, Imamoto A, Fiering S, Herzenberg LA, Kerr WG, Soriano P. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci U S A. 1997;94(8):3789-3794. (Pubitemid 27180451)
76. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207-210. (Pubitemid 34679544)
77. Fisher S, Grice EA, Vinton RM, Bessling SL, McCallion AS. Conservation of RET regulatory function from human to zebrafish without sequence similarity. Science. 2006;312(5771):276-279.
78. Fisher S, et al. Evaluating the biological relevance of putative enhancers using Tol2 transposon-mediated transgenesis in zebrafish. Nat Protoc. 2006; 1(3):1297-1305.
79. Kawakami K, Takeda H, Kawakami N, Kobayashi M, Matsuda N, Mishina M. A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish. Dev Cell. 2004;7(1):133-144. (Pubitemid 39172695)
80. Valouev A, et al. Genome-wide analysis of transcription factor binding sites based on ChIP-seq data. Nat Methods. 2008;5(9):829-834.
81. Kent WJ, et al. The human genome browser at UCSC. Genome Res. 2002;12(6):996-1006.
82. Smit AFA, Hubley R, Green P. RepeatMasker Open- 3.0 [computer program]. Seattle, Washington, USA: Institute for Systems Biology; 1996-2010.
83. Bailey TL, Elkan C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol. 1994;2:28-36.
84. Mahony S, Benos PV. STAMP: a web tool for exploring DNA-binding motif similarities. Nucleic Acids Res. 2007;35(Web Server issue):W253-W258.
85. Frith MC, Fu Y, Yu L, Chen JF, Hansen U, Weng Z. Detection of functional DNA motifs via statistical over-representation. Nucleic Acids Res. 2004; 32(4):1372-1381. (Pubitemid 38854738)
86. Aerts S, Thijs G, Coessens B, Staes M, Moreau Y, De Moor B. Toucan: deciphering the cis-regulatory logic of coregulated genes. Nucleic Acids Res. 2003;31(6):1753-1764. (Pubitemid 36336577)
87. The R Development Core Team. R: A Language And Environment For Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2010.
88. Taher L, Ovcharenko I. Variable locus length in the human genome leads to ascertainment bias in functional inference for non-coding elements. Bioinformatics. 2009;25(5):578-584.
89. Siepel A, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005;15(8):1034-1050. (Pubitemid 41126859)